317-52-2C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21.[Br-].[Br-]WDEFPRUEZRUYNW-UHFFFAOYSA-LSee also: Hexafluorenium (has active moiety).
317-52-2DTXSID6048753CHEMBL1200933FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses.
現在のフィルター条件では反応記録がありません。
読み込み中…